Literature DB >> 31508998

Failures, Reoperations, and Improvement in Knee Symptoms Following Matrix-Assisted Autologous Chondrocyte Transplantation: A Meta-Analysis of Prospective Comparative Trials.

Joshua S Everhart1, Eric X Jiang1, Sarah G Poland1, Amy Du1, David C Flanigan1.   

Abstract

OBJECTIVE: Though multiple high-level comparative studies have been performed for matrix-assisted autologous chondrocyte transplantation (MACT), quantitative reviews synthesizing best-available clinical evidence on the topic are lacking.
DESIGN: A meta-analysis was performed of prospective randomized or nonrandomized comparative studies utilizing MACT. A total of 13 studies reporting 13 prospective trials (9 randomized, 5 nonrandomized) were included (658 total study participants at weighted mean 3.1 years follow-up, range 1-7.5 years).
RESULTS: Reporting and methodological quality was moderate according to mean Coleman (59.4 SD 7.6), Delphi (3.0 SD 2.1), and MINORS (Methodological Index For Non-Randomized Studies) scores (20.2 SD 1.6). There was no evidence of small study or reporting bias. Effect sizes were not correlated with reporting quality, financial conflict of interest, sample size, year of publication, or length of follow-up (P > 0.05). Compared to microfracture, MACT had greater improvement in International Knee Documentation Committee (IKDC)-subjective and Knee Injury and Osteoarthritis Outcome Pain Subscale Score (KOOS)-pain scores in randomized studies (P < 0.05). Accelerated weight-bearing protocols (6 or 8 weeks) resulted in greater improvements in IKDC-subjective and KOOS-pain scores than standard protocols (8 or 11 weeks) for MACT in randomized studies (P < 0.05) with insufficient nonrandomized studies for pooled analysis.
CONCLUSIONS: Compared to microfracture, MACT has no increased risk of clinical failure and superior improvement in patient-reported outcome scores. Compared to MACT with standardized postoperative weight-bearing protocols, accelerated weight-bearing protocols have no increased risk of clinical failure and show superior improvement in patient-reported outcome scores. There is limited evidence regarding MACT compared to first-generation autologous chondrocyte implantation, mosaicplasty, and mesenchymal stem cell therapy without compelling differences in outcomes.

Entities:  

Keywords:  clinical failures; knee cartilage defects; matrix-assisted autologous chondrocyte transplantation; patient-reported outcomes; reoperations

Mesh:

Year:  2019        PMID: 31508998      PMCID: PMC8808777          DOI: 10.1177/1947603519870861

Source DB:  PubMed          Journal:  Cartilage        ISSN: 1947-6035            Impact factor:   3.117


  45 in total

1.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

2.  Minimum ten-year results of a prospective randomised study of autologous chondrocyte implantation versus mosaicplasty for symptomatic articular cartilage lesions of the knee.

Authors:  G Bentley; L C Biant; S Vijayan; S Macmull; J A Skinner; R W J Carrington
Journal:  J Bone Joint Surg Br       Date:  2012-04

Review 3.  Autologous chondrocyte implantation in the knee: systematic review and economic evaluation.

Authors:  Hema Mistry; Martin Connock; Joshua Pink; Deepson Shyangdan; Christine Clar; Pamela Royle; Rachel Court; Leela C Biant; Andrew Metcalfe; Norman Waugh
Journal:  Health Technol Assess       Date:  2017-02       Impact factor: 4.014

4.  Effect of accelerated weightbearing after matrix-associated autologous chondrocyte implantation on the femoral condyle: a prospective, randomized controlled study presenting MRI-based and clinical outcomes after 5 years.

Authors:  Barbara Wondrasch; May-Arna Risberg; Lukas Zak; Stefan Marlovits; Silke Aldrian
Journal:  Am J Sports Med       Date:  2014-11-06       Impact factor: 6.202

5.  NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions: an FDA phase-II prospective, randomized clinical trial after two years.

Authors:  Dennis C Crawford; Thomas M DeBerardino; Riley J Williams
Journal:  J Bone Joint Surg Am       Date:  2012-06-06       Impact factor: 5.284

6.  Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study.

Authors:  W Bartlett; J A Skinner; C R Gooding; R W J Carrington; A M Flanagan; T W R Briggs; G Bentley
Journal:  J Bone Joint Surg Br       Date:  2005-05

7.  Clinical and radiographical ten years long-term outcome of microfracture vs. autologous chondrocyte implantation: a matched-pair analysis.

Authors:  Robert Ossendorff; Kilian Franke; Benjamin Erdle; Markus Uhl; Norbert P Südkamp; Gian M Salzmann
Journal:  Int Orthop       Date:  2018-06-16       Impact factor: 3.075

8.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation.

Authors:  M Brittberg; A Lindahl; A Nilsson; C Ohlsson; O Isaksson; L Peterson
Journal:  N Engl J Med       Date:  1994-10-06       Impact factor: 91.245

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

Review 10.  The present state of treatments for articular cartilage defects in the knee.

Authors:  J R Perera; P D Gikas; G Bentley
Journal:  Ann R Coll Surg Engl       Date:  2012-09       Impact factor: 1.891

View more
  8 in total

Review 1.  The advances in nanomedicine for bone and cartilage repair.

Authors:  Kai Qiao; Lu Xu; Junnan Tang; Qiguang Wang; Khoon S Lim; Gary Hooper; Tim B F Woodfield; Guozhen Liu; Kang Tian; Weiguo Zhang; Xiaolin Cui
Journal:  J Nanobiotechnology       Date:  2022-03-18       Impact factor: 10.435

2.  Promoting endogenous articular cartilage regeneration using extracellular matrix scaffolds.

Authors:  David C Browe; Ross Burdis; Pedro J Díaz-Payno; Fiona E Freeman; Jessica M Nulty; Conor T Buckley; Pieter A J Brama; Daniel J Kelly
Journal:  Mater Today Bio       Date:  2022-07-05

3.  Arthroscopic Matrix-Encapsulated Autologous Chondrocyte Implantation: A Pilot Multicenter Investigation in Latin America.

Authors:  Enrique Villalobos; Antonio Madrazo-Ibarra; Valentín Martínez; Anell Olivos-Meza; Cristina Velasquillo; Socorro Cortés González; Aldo Izaguirre; Carmina Ortega-Sánchez; Ricardo González; Carmen Parra-Cid; Francisco Javier Pérez-Jiménez; Clemente Ibarra
Journal:  Cartilage       Date:  2020-05-14       Impact factor: 3.117

4.  Third-Generation Autologous Chondrocyte Implantation at the Knee Joint Using the Igor Scaffold: A Case Series With 2-Year Follow-up.

Authors:  Lukas Zak; Anne Kleiner; Christian Albrecht; Brigitte Tichy; Silke Aldrian
Journal:  Orthop J Sports Med       Date:  2021-01-22

5.  Excellent histological results in terms of articular cartilage regeneration after spheroid-based autologous chondrocyte implantation (ACI).

Authors:  David Grevenstein; Andreas Mamilos; Volker H Schmitt; Tanja Niedermair; Willi Wagner; C James Kirkpatrick; Christoph Brochhausen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-04-10       Impact factor: 4.342

6.  A phase I/IIa clinical trial of third-generation autologous chondrocyte implantation (IK-01) for focal cartilage injury of the knee.

Authors:  Takehiko Matsushita; Tomoyuki Matsumoto; Daisuke Araki; Kanto Nagai; Yuichi Hoshino; Takahiro Niikura; Atsuhiko Kawamoto; Masahiro J Go; Shin Kawamata; Masanori Fukushima; Ryosuke Kuroda
Journal:  Asia Pac J Sports Med Arthrosc Rehabil Technol       Date:  2022-03-28

Review 7.  Recent Developments and Current Applications of Organic Nanomaterials in Cartilage Repair.

Authors:  Zhanqi Wei; Ganlin Zhang; Qing Cao; Tianhao Zhao; Yixin Bian; Wei Zhu; Xisheng Weng
Journal:  Bioengineering (Basel)       Date:  2022-08-15

Review 8.  The Use of Nanomaterials in Tissue Engineering for Cartilage Regeneration; Current Approaches and Future Perspectives.

Authors:  Aziz Eftekhari; Solmaz Maleki Dizaj; Simin Sharifi; Sara Salatin; Yalda Rahbar Saadat; Sepideh Zununi Vahed; Mohammad Samiei; Mohammadreza Ardalan; Maryam Rameshrad; Elham Ahmadian; Magali Cucchiarini
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.